|
Qualigen Therapeutics Inc (NASDAQ: QLGN) |
|
Qualigen Therapeutics Inc
QLGN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Qualigen Therapeutics Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Qualigen Therapeutics Inc net loss decreased from $-4 millions, to $-2 millions in III. Quarter 2024,
• More on QLGN's Growth
|
|
Qualigen Therapeutics Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.01 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
3093.52 |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.
• More on QLGN's Valuation
|
|
|
|
|
Qualigen Therapeutics Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.01 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
3093.52 |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.
• More on QLGN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com